+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Peptide Antibiotics Market by Product, Application, End Use, Route Of Administration, Distribution Channel, Formulation, Source, Technology - Global Forecast to 2030- Product Image
Peptide Antibiotics Market by Product, Application, End Use, Route Of Administration, Distribution Channel, Formulation, Source, Technology - Global Forecast to 2030- Product Image
Sale

Peptide Antibiotics Market by Product, Application, End Use, Route Of Administration, Distribution Channel, Formulation, Source, Technology - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666281
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The peptide antibiotics market is positioned for significant growth as concerns about antimicrobial resistance intensify and industry stakeholders seek novel approaches for infection control and food safety. With robust advancements in peptide technology and evolving regulatory frameworks, leaders across pharmaceutical, veterinary, and food sectors are actively considering investment and strategic alignment in this dynamic ecosystem.

Market Snapshot: Peptide Antibiotics Market Outlook

The peptide antibiotics market grew from USD 5.58 billion in 2024 to USD 6.15 billion in 2025. It is expected to continue growing at a CAGR of 9.84%, reaching USD 9.81 billion by 2030. The growth trajectory underscores the essential role peptide-based antimicrobials play as traditional antibiotics confront mounting resistance challenges. Key factors driving expansion include the integration of advanced delivery systems, accelerated regulatory pathways, and rising demand across healthcare and food preservation applications in major regions.

Scope & Segmentation

  • Product Types: Bacitracin, Colistin, Daptomycin, Polymyxin B
  • Applications: Hospital use, outpatient care, food preservation, companion animal treatments, livestock management
  • End Use Environments: Clinics, ambulatory surgical centers, specialty clinics, private hospitals, public hospitals, veterinary clinics
  • Administration Routes: Intramuscular, intravenous, oral, topical
  • Distribution Channels: Direct tender, hospital pharmacy, online pharmacy, retail pharmacy
  • Formulations: Lyophilized powder injectables, solutions, powders, topical creams, ointments
  • Source Materials: Natural extracts and synthetic constructs
  • Technologies: Conventional, liposomal formulation, nanoencapsulation
  • Regions Covered: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (20+ key countries), Asia-Pacific (China, India, Japan, Australia, and more)
  • Companies Analyzed: Merck & Co., Inc., Pfizer Inc., Astellas Pharma Inc., F. Hoffmann-La Roche Ltd., Sanofi S.A., GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Fresenius Kabi AG, Hikma Pharmaceuticals PLC

Key Takeaways for Decision Makers

  • Peptide antibiotics offer differentiated mechanisms versus traditional drugs, creating significant opportunities for tackling multidrug-resistant infections.
  • Technological advances in liposomal and nanoencapsulation formulations are enhancing delivery, stability, and patient compliance across therapeutic settings.
  • Strategic collaborations—combining pharmaceutical, research, and supply chain expertise—accelerate preclinical development and broaden market access, particularly in high-growth Asia-Pacific and Latin American regions.
  • Product innovation is increasingly driven by the need for robust supply chain resilience, including vertical integration of synthesis and formulation capabilities.
  • Higher clinical adoption stems from combined hospital and outpatient strategies, while food and veterinary uses expand overall market applicability.
  • Lifecycle management, including reformulations and stewardship initiatives, supports extended product viability and regulatory acceptance.

Tariff Impact

The 2025 introduction of revised United States tariffs on peptide antibiotic precursors and formulation materials imposed near-term cost pressures on supply chain participants. Manufacturers responded by accelerating investments in domestic synthesis and in-house processing to manage rising input costs, drive cost certainty, and reinforce supply chain strength. Buyers diversified procurement strategies, resulting in new distribution agreements that have stabilized market pricing and fostered a more regionally balanced production network.

Methodology & Data Sources

This report utilizes primary interviews with global industry executives, procurement specialists, and opinion leaders across pharmaceutical, veterinary, and food safety fields. Secondary research draws from regulatory documents, patent filings, corporate disclosures, and peer-reviewed literature. Data triangulation aligns forecasts, supply chain adjustments, and adoption projections, with qualitative workshops lending insight into technology trends and resistance profiles.

Why This Report Matters

  • Enables senior executives to confidently prioritize investments in high-growth peptide antibiotic segments based on regional and application-specific insights.
  • Supports risk mitigation with actionable intelligence on tariff impacts, innovation trends, and competitive positioning shaping procurement and R&D strategies.

Conclusion

The peptide antibiotics market is rapidly evolving, propelled by adoption in healthcare, veterinary, and food safety sectors. Informed, strategic decisions grounded in robust analysis will position stakeholders to capture emerging opportunities and mitigate future disruption.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Peptide Antibiotics Market, by Product
8.1. Introduction
8.2. Bacitracin
8.3. Colistin
8.4. Daptomycin
8.5. Polymyxin B
9. Peptide Antibiotics Market, by Application
9.1. Introduction
9.2. Clinical Use
9.2.1. Hospital Use
9.2.2. Outpatient Care
9.3. Food Preservation
9.4. Veterinary Use
9.4.1. Companion Animals
9.4.2. Livestock
10. Peptide Antibiotics Market, by End Use
10.1. Introduction
10.2. Clinics
10.2.1. Ambulatory Surgical Centers
10.2.2. Specialty Clinics
10.3. Hospitals
10.3.1. Private Hospitals
10.3.2. Public Hospitals
10.4. Veterinary Clinics
11. Peptide Antibiotics Market, by Route Of Administration
11.1. Introduction
11.2. Intramuscular
11.3. Intravenous
11.4. Oral
11.5. Topical
12. Peptide Antibiotics Market, by Distribution Channel
12.1. Introduction
12.2. Direct Tender
12.3. Hospital Pharmacy
12.4. Online Pharmacy
12.5. Retail Pharmacy
13. Peptide Antibiotics Market, by Formulation
13.1. Introduction
13.2. Injectable
13.2.1. Lyophilized Powder
13.2.2. Solution
13.3. Powder
13.4. Topical Formulation
13.4.1. Cream
13.4.2. Ointment
14. Peptide Antibiotics Market, by Source
14.1. Introduction
14.2. Natural
14.3. Synthetic
15. Peptide Antibiotics Market, by Technology
15.1. Introduction
15.2. Conventional
15.3. Liposomal Formulation
15.4. Nanoencapsulation
16. Americas Peptide Antibiotics Market
16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. Argentina
17. Europe, Middle East & Africa Peptide Antibiotics Market
17.1. Introduction
17.2. United Kingdom
17.3. Germany
17.4. France
17.5. Russia
17.6. Italy
17.7. Spain
17.8. United Arab Emirates
17.9. Saudi Arabia
17.10. South Africa
17.11. Denmark
17.12. Netherlands
17.13. Qatar
17.14. Finland
17.15. Sweden
17.16. Nigeria
17.17. Egypt
17.18. Turkey
17.19. Israel
17.20. Norway
17.21. Poland
17.22. Switzerland
18. Asia-Pacific Peptide Antibiotics Market
18.1. Introduction
18.2. China
18.3. India
18.4. Japan
18.5. Australia
18.6. South Korea
18.7. Indonesia
18.8. Thailand
18.9. Philippines
18.10. Malaysia
18.11. Singapore
18.12. Vietnam
18.13. Taiwan
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. Merck & Co., Inc.
19.3.2. Pfizer Inc.
19.3.3. Astellas Pharma Inc.
19.3.4. F. Hoffmann-La Roche Ltd.
19.3.5. Sanofi S.A.
19.3.6. GlaxoSmithKline plc
19.3.7. Teva Pharmaceutical Industries Ltd.
19.3.8. Sandoz International GmbH
19.3.9. Fresenius Kabi AG
19.3.10. Hikma Pharmaceuticals PLC
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. PEPTIDE ANTIBIOTICS MARKET MULTI-CURRENCY
FIGURE 2. PEPTIDE ANTIBIOTICS MARKET MULTI-LANGUAGE
FIGURE 3. PEPTIDE ANTIBIOTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 20. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 22. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 26. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. ASIA-PACIFIC PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. ASIA-PACIFIC PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. PEPTIDE ANTIBIOTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 32. PEPTIDE ANTIBIOTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. PEPTIDE ANTIBIOTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY BACITRACIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY COLISTIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY DAPTOMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY POLYMYXIN B, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITAL USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY OUTPATIENT CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY FOOD PRESERVATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY USE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOLUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY CREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY OINTMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY LIPOSOMAL FORMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY NANOENCAPSULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY USE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY USE, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 88. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, 2018-2030 (USD MILLION)
TABLE 91. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY USE, 2018-2030 (USD MILLION)
TABLE 92. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 93. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 94. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 95. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 96. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 98. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 99. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 100. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 101. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 102. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, 2018-2030 (USD MILLION)
TABLE 105. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY USE, 2018-2030 (USD MILLION)
TABLE 106. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 107. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 108. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 109. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 110. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 112. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 113. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 114. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 115. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY USE, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY USE, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY USE, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY USE, 2018-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 164. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 166. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 170. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 172. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, 2018-2030 (USD MILLION)
TABLE 176. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY USE, 2018-2030 (USD MILLION)
TABLE 177. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 178. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 179. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 180. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 181. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 183. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 184. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 185. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 186. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, 2018-2030 (USD MILLION)
TABLE 190. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY USE, 2018-2030 (USD MILLION)
TABLE 191. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 192. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 193. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 194. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 195. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 196. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 197. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 198. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 199. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 200. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 202. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, 2018-2030 (USD MILLION)
TABLE 204. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY USE, 2018-2030 (USD MILLION)
TABLE 205. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 206. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 207. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 208. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 209. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 210. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 211. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 212. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 213. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 214. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 216. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, 2018-2030 (USD MILLION)
TABLE 218. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY USE, 2018-2030 (USD MILLION)
TABLE 219. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 220. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 221. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 222. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 223. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 225. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 226. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 227. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 228. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 229. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 230. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, 2018-2030 (USD MILLION)
TABLE 232. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY USE, 2018-2030 (USD MILLION)
TABLE 233. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 234. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 235. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 236. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 237. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 239. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 240. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 241. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 242. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 243. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, 2018-2030 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY USE, 2018-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 258. SAUDI ARABIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, 2018-2030 (USD MILLION)
TABLE 260. SAUDI ARABIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY USE, 2018-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 262. SAUDI ARABIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 264. SAUDI ARABIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 266. SAUDI ARABIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 268. SAUDI ARABIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 271. SOUTH AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 272. SOUTH AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, 2018-2030 (USD MILLION)
TABLE 274. SOUTH AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY USE, 2018-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 276. SOUTH AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 285. DENMARK PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 286. DENMARK PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. DENMARK PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, 2018-2030 (USD MILLION)
TABLE 288. DENMARK PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY USE, 2018-2030 (USD MILLION)
TABLE 289. DENMARK PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 290. DENMARK PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 291. DENMARK PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 292. DENMARK PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 293. DENMARK PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 294. DENMARK PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 295. DENMARK PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 296. DENMARK PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 297. DENMARK PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 298. DENMARK PEPTIDE ANTIBIOTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 299. NETHERLANDS PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 300. NETHERLANDS PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. NETHERLANDS PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, 2018-2030 (USD MILLION)
TABLE 302. NETHERLANDS PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY USE, 2018-2030 (USD MILLION)
TABLE 303. NETHERLANDS PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 304. NETHERLANDS PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 305. NETHERLANDS PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 306. NETHERLANDS PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 307. NETHERLANDS PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 308. NETHERLANDS PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 309. NETHERLANDS PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 310. NETHERLANDS PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 311. NETHERLANDS PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 312. NETHERLANDS PEPTIDE ANTIBIOTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 313. QATAR PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 314. QATAR PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 315. QATAR PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, 2018-2030 (USD MILLION)
TABLE 316. QATAR PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY USE, 2018-2030 (USD MILLION)
TABLE 317. QATAR PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 318. QATAR PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 319. QATAR PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 320. QATAR PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 321. QATAR PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 322. QATAR PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 323. QATAR PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 324. QATAR PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 325. QATAR PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 326. QATAR PEPTIDE ANTIBIOTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 327. FINLAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 328. FINLAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 329. FINLAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, 2018-2030 (USD MILLION)
TABLE 330. FINLAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY USE, 2018-2030 (USD MILLION)
TABLE 331. FINLAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 332. FINLAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 333. FINLAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 334. FINLAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 335. FINLAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 336. FINLAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 337. FINLAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 338. FINLAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 339. FINLAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 340. FINLAND PEPTIDE ANTIBIOTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 341. SWEDEN PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 342. SWEDEN PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 343. SWEDEN PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, 201

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Peptide Antibiotics market report include:
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Astellas Pharma Inc.
  • F. Hoffmann-La Roche Ltd.
  • Sanofi S.A.
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Fresenius Kabi AG
  • Hikma Pharmaceuticals PLC

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.15 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.81 Billion
Compound Annual Growth Rate9.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Peptide Antibiotics Market Size, Share & Trends Analysis Report By Disease (Skin Infection, HABP/VABP), By Route of Administration (Injectable, Oral), By Product, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Peptide Antibiotics Market Size, Share & Trends Analysis Report By Disease (Skin Infection, HABP/VABP), By Route of Administration (Injectable, Oral), By Product, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Peptide Antibiotics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Peptide Antibiotics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Peptide Antibiotics - Global Strategic Business Report - Product Image

Peptide Antibiotics - Global Strategic Business Report

  • Report
  • 381 Pages
  • Global
From
Peptide Antibiotics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Peptide Antibiotics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 130 Pages
  • Global
From
Peptide Antibiotics Market Report 2025 - Product Image

Peptide Antibiotics Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Peptide Antibiotics Market

Peptide antibiotics are a type of antibiotic derived from peptides, which are short chains of amino acids. They are used to treat a variety of bacterial infections, including those caused by Gram-positive and Gram-negative bacteria. Peptide antibiotics are generally more effective than traditional antibiotics, as they are able to target specific bacterial cells and are less likely to cause resistance. They are also less likely to cause side effects, such as nausea and vomiting. Peptide antibiotics are typically administered intravenously or intramuscularly, and can be used in combination with other antibiotics. The peptide antibiotics market is growing rapidly, driven by the increasing prevalence of antibiotic-resistant bacteria and the need for more effective treatments. The market is expected to continue to grow in the coming years, as more research is conducted into the development of new peptide antibiotics. Some companies in the peptide antibiotics market include Merck, Pfizer, GlaxoSmithKline, Sanofi, and AstraZeneca. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.